Skip to main content
Log in

Challenges and recommendations for epigenomics in precision health

  • Correspondence
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

References

  1. Anonymous. GWG Life becomes first insurtech firm to collect epigenetic samples to analyze biomarkers of life insurance policy owners. https://globenewswire.com/news-release/2017/03/02/930557/0/en/GWG-Life-Becomes-First-Insurtech-Firm-to-Collect-Epigenetic-Samples-to-Analyze-Biomarkers-of-Life-Insurance-Policy-Owners.html (2017).

  2. Chen, B.H. et al. Aging 8, 1844–1865 (2016).

    Article  CAS  Google Scholar 

  3. Cloud, J. Why your DNA isn't your destiny. Time http://content.time.com/time/subscriber/article/0,33009,1952313-2,00.html (2010).

    Google Scholar 

  4. Moskowitz, X. et al. Sci. Immunol. 2, 1–2 (2016).

    Google Scholar 

  5. Sen, D.R. et al. Science 354, 1165–1169 (2016).

    Article  CAS  Google Scholar 

  6. Qu, K. et al. Cancer Cell 32, 27–41.e4 (2017).

    Article  CAS  Google Scholar 

  7. Joehanes, R. et al. Circ. Cardiovasc. Genet. 9, 436–447 (2016).

    Article  CAS  Google Scholar 

  8. Snyder, M.W., Kircher, M., Hill, A.J., Daza, R.M. & Shendure, J. Cell 164, 57–68 (2016).

    Article  CAS  Google Scholar 

  9. Soon, W.W., Hariharan, M. & Snyder, M.P. Mol. Syst. Biol. 9, 640 (2013).

    Article  Google Scholar 

  10. Fraga, M.F. et al. Proc. Natl. Acad. Sci. USA 102, 10604–10609 (2005).

    Article  CAS  Google Scholar 

  11. Castillo-Fernandez, J.E., Spector, T.D. & Bell, J.T. Genome Med. 6, 60 (2014).

    Article  Google Scholar 

  12. McGuire, A.L., Caulfield, T. & Cho, M.K. Nat. Rev. Genet. 9, 152–156 (2008).

    Article  CAS  Google Scholar 

  13. Allis, C.D. & Jenuwein, T. Nat. Rev. Genet. 17, 487–500 (2016).

    Article  CAS  Google Scholar 

  14. Buenrostro, J.D., Giresi, P.G., Zaba, L.C., Chang, H.Y. & Greenleaf, W.J. Nat. Methods 10, 1213–1218 (2013).

    Article  CAS  Google Scholar 

  15. Adey, A. & Shendure, J. Genome Res. 22, 1139–1143 (2012).

    Article  CAS  Google Scholar 

  16. Schmidl, C., Rendeiro, A.F., Sheffield, N.C. & Bock, C. Nat. Methods 12, 963–965 (2015).

    Article  CAS  Google Scholar 

  17. Fraser, M. et al. Nature 541, 359–364 (2017).

    Article  CAS  Google Scholar 

  18. Soshnev, A.A., Josefowicz, S.Z. & Allis, C.D. Mol. Cell 62, 681–694 (2016).

    Article  CAS  Google Scholar 

  19. Jiang, L. et al. Genome Res. 21, 1543–1551 (2011).

    Article  CAS  Google Scholar 

  20. Zook, J.M. et al. Sci. Data 3, 160025 (2016).

    Article  CAS  Google Scholar 

  21. Gray, K.A., Seal, R.L., Tweedie, S., Wright, M.W. & Bruford, E.A. Hum. Genomics 10, 6 (2016).

    Article  Google Scholar 

  22. Mockus, S.M., Patterson, S.E., Statz, C., Bult, C.J. & Tsongalis, G.J. Clin. Chem. 62, 442–448 (2016).

    Article  CAS  Google Scholar 

  23. Wright, M.W. & Bruford, E.A. Hum. Genomics 5, 90–98 (2011).

    Article  CAS  Google Scholar 

  24. Kellis, M. et al. Proc. Natl. Acad. Sci. USA 111, 6131–6138 (2014).

    Article  CAS  Google Scholar 

  25. The ENCODE Project Consortium. Nature 489, 57–74 (2012).

  26. Roadmap Epigenomics Consortium. Nature 518, 317–330 (2015).

  27. The FANTOM Consortium. Nature 507, 455–461 (2014).

  28. Malladi, V.S. et al. Database 2015, bav010 (2015).

    Article  Google Scholar 

  29. Newman, A.M. et al. Nat. Med. 20, 548–554 (2014).

    Article  CAS  Google Scholar 

  30. Fan, H.C. et al. Nature 487, 320–324 (2012).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank J.A. Stamatoyannopoulos (U. Washington), C.-T. Wu (Harvard Medical School) and J. Schloss (NHGRI) for input. We thank the National Human Genome Research Institute for support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Howard Y Chang.

Ethics declarations

Competing interests

H.Y.C. is a co-founder and serves on the SAB of Accent Therapeutics and Epinomics; G.C. has the following financial interests (arep.med.harvard.edu/gmc/tech.html); A.D. is CEO of Before Brands; J.R.E. is a member of the scientific advisory board of Epinomics and Pathway Genomics; E.G. is the co-founder and chairman of Color Genomics and an investor in WholeBiome, Karius, Epinomics, and Encoded Genomics; P.G.G. is a co-founder of Epinomics; W.J.G. is a co-founder of Epinomics; C.H. is a scientific founder of Accent Therapeutics; M.P.S. is a founder and member of the science advisory board of Personalis and Qbio, and a science advisory board member of Genapsys and Epinomics; J.T. is an employee of 23andMe; M.V. serves as a member of the SAB of seqWell.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carter, A., Chang, H., Church, G. et al. Challenges and recommendations for epigenomics in precision health. Nat Biotechnol 35, 1128–1132 (2017). https://doi.org/10.1038/nbt.4030

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.4030

  • Springer Nature America, Inc.

This article is cited by

Navigation